These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 4729052

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Fibrinolysis in normal plasma and blood: evidence for significant mechanisms independent of the plasminogen-plasmin system.
    Moroz LA, Gilmore NJ.
    Blood; 1976 Oct; 48(4):531-45. PubMed ID: 134751
    [Abstract] [Full Text] [Related]

  • 27. A plasminogen proactivator-activator system in human blood effective in absence of Hageman Factor.
    Astrup T, Rosa AT.
    Thromb Res; 1974 Apr; 4(4):609-13. PubMed ID: 4428468
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S.
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, hageman factor, prekallikrein, high molecular weight kininogen, and factor XI.
    Kaplan AP.
    Prog Hemost Thromb; 1978 Sep; 4():127-75. PubMed ID: 362477
    [No Abstract] [Full Text] [Related]

  • 34. Prekallikrein and plasminogen proactivator: absence of plasminogen proactivator in Fletcher factor deficient plasma.
    Venneröd AM, Laake K.
    Thromb Res; 1976 Apr; 8(4):519-22. PubMed ID: 1273811
    [No Abstract] [Full Text] [Related]

  • 35. Chloroform-induced fibrinolysis. Its dependence on Hageman factor, plasma prekallikrein, and high molecular weight kininogen.
    Gordon EM, Ratnoff OD, Goldsmith GH.
    J Lab Clin Med; 1980 Apr; 95(4):507-14. PubMed ID: 7359011
    [Abstract] [Full Text] [Related]

  • 36. Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.
    Schreiber AD, Kaplan AP, Austen KF.
    J Clin Invest; 1973 Jun; 52(6):1402-9. PubMed ID: 4703226
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H, Ratnoff OD.
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.